Gentle craniosacral therapy tested to ease breast cancer After-Effects

NCT ID NCT04319510

Completed Symptom relief Sponsor: Universität Duisburg-Essen Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether craniosacral therapy, a gentle hands-on technique, can improve quality of life in women who have finished breast cancer treatment. 102 survivors with reduced well-being are randomly assigned to one-on-one therapy, group self-help training, or a waiting list. Researchers measure changes in cancer-related quality of life after 12 and 26 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: craniosacral therapy (a gentle hands-on technique)
What this could lead to: If it works, this could offer a safe, drug-free way to help breast cancer survivors feel better and improve their daily quality of life.
What could go wrong: This is a small, early-stage trial with no blinding, so results may be influenced by placebo effects. The therapy is complementary and not a treatment for cancer itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER COMPLEMENTARY THERAPIES

Contacts and locations

Locations

Breast Unit, Evang. Kliniken Essen-Mitte

Essen, 45276, Germany
Center for Integrative Medicine and Planetary Health, University Hospital Essen, University of Duisburg-Essen

Essen, 45130, Germany
Department of Gynecology and Obstetrics, University Hospital Essen, University of Duisburg-Essen

Essen, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.